The protamine locus consists of a 28.5 kb region with a linear array of the protamine (PRM)1, PRM2, PRM3 and transition nuclear protein (TNP)2 genes. Several studies indicate an abnormal expression pattern of protamine genes associated with male infertility, although the molecular mechanism underlying this observation is unclear. Here, we determined the spectrum of DNA variants present in all four genes in men with unexplained infertility compared with an ancestry-matched fertile/normospermic population. A total of 160 control individuals and at least 125 infertile men with either idiopathic azoospermia or oligozoospermia were sequenced for the open reading frame of PRM1, PRM2, PRM3 and TNP2 genes. All individuals carried an apparently intact Y chromosome. Of the 28 variants identified, 21 were previously described in the literature. The novel variants that were observed only in the infertile cohort included the SNP c.65G.A mutation which resulted in an amino acid change at the codon 22 (p.Ser22Asn) in the PRM1 gene, a mutation in the promoter region of PRM2 (267C.T) and a nonsense mutation in the PRM3 gene. These data are consistent with that of previous studies which have indicated that mutations in the protamine locus may be an infrequent cause of male infertility.
Introduction
Protamines, the major nuclear sperm proteins, are small basic proteins that are widely conserved between species (Corzett et al., 2002) . All mammals have at least one protamine gene, PRM1, whereas some species including the human and mouse have a second protamine, PRM2. Both proteins are rich in arginine and cysteine amino acids that are needed for DNA binding and disulphide bridge formation (Oliva and Dixon, 1991) .
Mature spermatozoa are formed during spermiogenesis by complex morphological, biochemical and physiological modifications. In the round spermatid, the nucleus elongates and histones are replaced by transition nuclear proteins (TNPs), which are in turn removed and replaced by protamines in elongating spermatids (Shirley et al., 2004) . These specific events are supported by spermiogenesis-specific gene products (Tanaka and Baba, 2005) .
A 28 kb region of human chromosome 16p13.13 contains the genes for the sperm-specific protamine 1, protamine 2, protamine 3 and transition protein 2 (Nelson and Krawetz, 1994) . PRM1 -PRM2 -TNP2 is a multigenic locus which therefore represents a single coordinately expressed chromatin domain (Kramer and Krawetz, 1998) . The protamine gene cluster contains a fourth gene, designed protamine 3 (PRM3), located between the PRM2 and TNP2 genes in rat, human and mouse (Schlüter et al., 1996; Schlüter and Engel, 1995) .
The DNA of human sperm is highly condensed in the sperm head by both PRM1 and PRM2 (Tanaka et al., 2003) . It has been suggested that disturbances in nuclear condensation might result in male infertility. Indeed, sperm protamine deficiency has been observed in some infertile men, suggesting that errors in chromatin packaging may be causing infertility (Tanaka et al., 2003; Iguchi et al., 2006) . In the mouse model, premature translation of PRM1 mRNA causes precocious nuclear condensation and arrests spermatid differentiation (Lee et al., 1995) . In various studies of infertile patients, a reduction in PRM2 content has been reported (Balhorn et al., 1988; Belokopytova et al., 1993) , and some infertile male patients have been shown to have a complete selective absence of PRM2 in the nuclei of their sperm (de Yebra et al., 1993) . In addition, it has been proposed that incomplete processing of the PRM2 precursor molecule might reduce the PRM2 levels in certain infertile patients (de Yebra et al., 1998) .
A small minority of infertile men carry missense or nonsense mutations in these genes that appear to be associated with the infertile phenotype (Ravel et al., 2007) . Recently, mutations in the promoter region of PRM1 have also been suggested to be a cause of infertility (Gázquez et al., 2008) . In this study, we screened for mutations in genes in the entire protamine locus in order to investigate whether variant protamine genes could be associated with infertility. We performed this study on a relatively homogenous North African population from Morocco in order to have appropriate ancestry-matched case and control subjects.
Materials and Methods
DNA samples from 160 control individuals and at least 125 infertile men with either idiopathic azoospermia or oligozoospermia were sequenced in the open reading frame of PRM1, PRM2, PRM3 and TNP2 (Table I ). All individuals were of Moroccan origin. All patients provided informed consent prior to participation in this study. All clinical investigations were conducted according to the principles expressed in the Declaration of Helsinki. The infertile patients were previously screened for Y chromosome microdeletions (Imken et al., 2007) as recommended by the EAA. Individuals carrying AZF microdeletions were excluded from further study. The control group was composed of 76 normospermic and 84 proven fertile volunteers (father of at least two children).
Primer sets were designed and optimized to amplify each of the PRM1, PRM2, PRM3, and TNP2 coding exons and flanking intronic sequences (Table II) . Standard polymerase chain reaction (PCR) techniques were used with the following thermocycling conditions: 958C for 5 min followed by 35 cycles of 948C for 30 s, annealing temperature for 30 s (P1: 598C; P2 and P3: 618C; TNP2: 638C), base extension at 728C for 30 s and a final hold for 5 min at 728C.
All PCR products were purified by incubation with Exonuclease I and shrimp alkaline phosphatase and directly sequenced using the ABI-Prism Big Dye terminator cycle sequencing Ready Reaction Kit V1.1 (ABI Prism/Applied Biosystems) and analyzed on an ABI-Prism 3700 Genetic Analyser (Applied Biosystems). The results were compared with the wildtype coding sequence of protamines genes using the ABI SecScape software version 2.2.
An SNP was confirmed by the direct sequencing of at least two independently prepared PCR products.
Statistical analysis
Differences in the genotypes between cases and controls were evaluated by Fisher's exact test. Statistical analysis of the data was performed on SPSS 11.0. A P-value of ,0.05 was considered statistically significant. All tests were two-tailed.
Results

Analysis of mutations detected in protamine locus
Protamine 1 Direct sequencing of the PCR-amplified DNA was performed by using genomic DNA from peripheral blood lymphocytes. Sequence analysis identified five variants. In a total of 295 subjects, which included 135 infertile men and 160 control subjects, three mutations were identified in the coding region at position c.54G.A, c.65G.A and c.139C.A and two mutations were identified in the 5 0 untranslated region. The c.65G.A variant is predicted to result in a serine to aspargine substitution (Fig. 1A) , and it was found in one infertile subject and was absent from the control group. The two mutations, c.54G.A and c.139C.A, were found in fertile and infertile subjects at similar allelic frequencies (Table III) .
Similarly the c.2191C.A variant in the 5 0 non-coding region was found in similar frequencies in both case and control groups. The c.2107G.C mutation in the 5 0 non-coding region was found only in the infertile group.
Protamine 2
We detected 10 variants involving the PRM2 gene, and these are listed in Table IV . The mutation c.267 C.T (Fig. 1B ) was found in a single patient with azoospermia. None of the nine mutations in the coding region was predicted to result in an amino acid change. Furthermore, seven of these mutations were detected in an intron, two of which were found only in the infertile population (c.381þ10C and c.381þ107G). The prevalence of the other intronic mutations in infertile males was similar to that in proven-fertile volunteers, except for the c.381þ10C which showed a significant difference between the fertile and infertile populations (P ¼ 0.043; Table IV Transition nuclear protein 2
The TNP2 gene (Nelson et al., 1993) was sequenced in the two groups of infertile patients and proven-fertile volunteers. A total of six mutations were identified in the TNP2 gene (Table V) . Four of these changes are known polymorphic variants but the c.76T.G mutation is novel (Fig. 1D) . The c.117G.C mutation was previously reported as a rare variant (Aoki et al., 2006) . None of the mutations were found exclusively in the infertile patients.
Protamine 3
Seven mutations were identified in the PRM3 gene in a total of 285 subjects (Table VI) . One mutation was observed in the 5 0 untranslated region, five in the coding sequencing and one in 3 0 untranslated region. Three novel heterozygous mutations (Fig. 1C) in the coding sequences were identified in the two groups. The c.65C.T (p.Thr22Met) mutation was identified in one control individual, and a c.66A.G silent mutation was identified in the same codon in one infertile individual. The third mutation was observed in one fertile individual (c.178G.T, pGly60Trp). Two other common polymorphisms were identified at similar frequencies in the coding sequences. The two mutations in the non-coding regions (c.*1C.T and c.225C.T) were detected at similar frequencies between the case and control groups. (2) 
Discussion
Numerous reports have emerged in the last decade establishing a relationship between abnormal protamine expression and male infertility (Carrell and Liu, 2001; Aoki et al., 2005) . Some infertile patients have altered P1:P2 ratios (Aoki et al., 2005 (Aoki et al., , 2006 . Mutation screens of infertile patient have identified variants in protamines genes in association with infertility (Iguchi et al., 2006; Ravel et al., 2007; Gázquez et al., 2008) . In our study, we determined the relationship between variations in PRM gene locus and male infertility in the Moroccan population. This population has a relatively homogenous structure and was thus suitable for association studies. We assessed the prevalence of sequence variants in individuals with unexplained infertility compared with a control population composed of 76 normospermic and 84 proven fertile volunteers. A single patient with idiopathic severe oligozoospermia had a previously unreported heterozygous mutation (c.65G.A, p.Ser22Asn) located within the central arginine-rich DNA-binding motif of PRM1. This mutation was not observed in the control population but the association of this mutation with the phenotype requires functional studies.
In the promoter region, c.(2107G.C) and c.(267C.T) variants were found in the PRM1 and PRM2 genes, respectively, in infertile cases (Table VII) . Studies by Ravel et al. (2007) have found the c.(2107G.C) variant only in an infertile group. Kichine et al. (2008) did not find this variant in a screen of 672 fertile men, but it was observed in 5 unselected men from the Comoros Islands and in 67 men from the Congo with unknown fertility. This suggests that it is a population specific variant. This mutation is located between sequences 277 and 2150 which are required for spermatid-specific transcription (Zambrowicz and Palmiter, 1994) . In our study, the c.(2107G.C) was identified in a patient with moderate oligozoospermia and was absent in 160 controls (76 normospermics and 84 fertile). Two regions in the PRM2 promoter, BS1 (64/248) and BS2 (287/267), are essential for transcription, since their removal or alteration leads to significant reduction in PRM2 transcription (Yiu and Hecht, 1997) . We identified a mutation in the BS2 motif (c.267C.T) in a patient with azoospermia suggesting that the mutation may interfere with PRM2 transcription. Likewise, we also identified a new variant in the intronic region c.381þ10C that showed a modest significant difference in incidences between the case and the control groups (P ¼ 0.043; Table IV ). Further case/ control studies are needed to confirm these associations, but it is possible that the C.T mutation contributes to the infertile phenotype by the creation of a novel donor splice site.
Screening the TNP2 gene showed no variants that were specifically associated with the infertile phenotype.
The PRM3 gene has been poorly studied, and many unanswered questions remain concerning its function, expression, regulation and phylogenetic distribution. Although this gene has been considered as a pseudo-gene, recent studies showed that this gene is conserved across diverse mammals, and there is some evidence that it may be functional, since mice that lack Prm3 showed reduced motility (Oliva, 2006; Grzmli et al., 2008) . This prompted us to test for mutations in the PRM3 gene. We identified five variants in the coding region, and three of these are novel mutations that are predicted to result in amino acid changes. However, only one mutation was found exclusively in the infertile patients, and the allelic frequency of all the variants that were identified did not show any significant differences between case and control groups (Table VI) . This result may support the fact that variants within protamine gene are not a frequent cause of infertility or that this gene is not functional. The four tightly linked genes in protamine cluster are expressed specifically in haploid spermatogenic cells in mammals. All the variants described potentially have a significant effect due to the haploid expression of these genes. Several of the mutations in the PRM1 and PRM2 genes described here may cause male infertility by altering gene expression or modifying RNA transcripts. However, mutations specifically associated with infertility were low, and these data are consistent with previous studies that indicate that mutations in the protamine locus are not a frequent cause of male infertility (Aoki et al., 2006; Ravel et al., 2007) .
